Background illustration for clinical trials search

Paid Clinical Trials El Paso

Discover 867 paid clinical trials in El Paso, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML

for
AML, Adult, MDS
Location: Aurora CO, St Louis MO, Duarte CA, Houston TX,
Sponsor: Stelexis BioSciences

Sex: All

Age: 18+

Code: NCT06533761

Phase1, Recruiting

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

for
Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer,
Location: Aurora CO, Oklahoma City OK, Irving TX, San Antonio TX,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06128551

Phase1, Phase2, Recruiting

Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors

for
Advanced Refractory Solid Tumors,
Location: Colorado Springs CO, California City CA, Texas City TX,
Sponsor: Cosmo Technologies Ltd

Sex: All

Age: 18+

Code: NCT03863145

Early_phase1, Recruiting

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

for
Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary,
Location: Aurora CO, Newport Beach CA, Los Angeles CA, Houston TX,
Sponsor: Volastra Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05902988

Phase1, Phase2, Recruiting

A Phase 1/1b Study of IAM1363 in HER2 Cancers

for
HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: Aurora CO, West Valley City UT, Oklahoma City OK,
Sponsor: Iambic Therapeutics, Inc

Sex: All

Age: 18+

Code: NCT06253871

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy

for
IgA Nephropathy
Location: Aurora CO, Albuquerque NM, El Paso TX, Odessa TX,
Sponsor: Calliditas Therapeutics AB

Sex: All

Age: 18+

Code: NCT06712407

Recruiting

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

for
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen,
Location: Aurora CO, Omaha NE, Rochester MN, Iowa City IA,
Sponsor: Servier Bio-Innovation LLC

Sex: All

Age: 18+

Code: NCT06127407

Phase3, Recruiting

CtDNA Based MRD Testing for NAC Monitoring in TNBC

for
TNBC - Triple-Negative Breast Cancer, Minimal Residual Disease
Location: Aurora CO, Omaha NE, Tucson AZ, Peoria IL, Spokane WA,
Sponsor: Personalis Inc.

Sex: Female

Age: 18+

Code: NCT06230185

Recruiting

Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate

for
Carcinoma, Squamous Cell
Location: Aurora CO, Dallas TX, Louisville KY, Columbia SC,
Sponsor: Introgen Therapeutics

Sex: All

Age: 18+

Code: NCT00041613

Phase3, Recruiting

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

for
Solid Tumors, Hematologic Malignancies
Location: Aurora CO, Tulsa OK, Las Vegas NV, Tucson AZ, Dallas TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT03486873

Phase3, Recruiting

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

for
Advanced Lung Cancer
Location: Aurora CO, Phoenix AZ, Dallas TX, Rochester MN,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06892548

Phase1, Phase2, Recruiting

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

for
Uterine Fibroids, Endometriosis
Location: Aurora CO, Greenwood Village CO, Lakewood CO,
Sponsor: Sumitomo Pharma Switzerland GmbH

Sex: Female

Age: 18 - 50

Code: NCT05862272

Phase3, Recruiting

An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene

for
Stargardt, Stargardt's Disease, Stargardt Disease, STGD1
Location: Aurora CO, Dallas TX, San Diego CA, Madison WI,
Sponsor: Splice Bio

Sex: All

Age: 12 - 65

Code: NCT06435000

Recruiting

A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)

for
Stargardt Disease, Stargardt Macular Degeneration,
Location: Aurora CO, Dallas TX, Portland OR, Miami FL, Boston MA
Sponsor: Splice Bio

Sex: All

Age: 12 - 65

Code: NCT06942572

Phase1, Phase2, Recruiting

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

for
Type 1 Diabetes Mellitus
Location: Aurora CO, Oklahoma City OK, Los Angeles CA, Houston TX,
Sponsor: Mannkind Corporation

Sex: All

Age: 6 - 17

Code: NCT07224321

Phase2, Recruiting

Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM) System

for
Diabetes Mellitus
Location: Aurora CO, Idaho Falls ID, San Antonio TX, Escondido CA
Sponsor: DexCom, Inc.

Sex: All

Age: 2+

Code: NCT04645641

Recruiting

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

for
Type 1 Diabetes
Location: Aurora CO, Kansas City MO, Fargo ND, Fort Worth TX,
Sponsor: SAb Biotherapeutics, Inc.

Sex: All

Age: 5 - 40

Code: NCT07187531

Phase2, Recruiting

A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

for
Diabetes Mellitus, Type 1
Location: Aurora CO, Corpus Christi TX, Vancouver, Tallahassee FL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 1 - 35

Code: NCT07222332

Phase3, Recruiting

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

for
Type 1 Diabetes Mellitus
Location: Aurora CO, Idaho Falls ID, Kansas City MO,
Sponsor: Sanofi

Sex: All

Age: 1 - 25

Code: NCT07088068

Phase3, Recruiting

TrialNet Pathway to Prevention of T1D

for
Diabetes Mellitus, Type 1
Location: Denver CO, Kansas City MO, Dallas TX, Minneapolis MN,
Sponsor: University of South Florida

Sex: All

Age: 2 - 45

Code: NCT00097292

Recruiting